List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Neuroprotection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuroprotection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuroprotection Overall Market Size
2.1 Global Neuroprotection Market Size: 2022 VS 2029
2.2 Global Neuroprotection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuroprotection Players in Global Market
3.2 Top Global Neuroprotection Companies Ranked by Revenue
3.3 Global Neuroprotection Revenue by Companies
3.4 Top 3 and Top 5 Neuroprotection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neuroprotection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuroprotection Players in Global Market
3.6.1 List of Global Tier 1 Neuroprotection Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuroprotection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuroprotection Market Size Markets, 2022 & 2029
4.1.2 Free Anti-Inflammatory Agents
4.1.3 Radical Trapping Agents (Antioxidants)
4.1.4 Apoptosis Inhibitors
4.1.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
4.1.6 Neurotrophic Factors (NTFs)
4.1.7 Stimulants
4.1.8 Metal Ion Chelators
4.1.9 Others
4.2 By Type - Global Neuroprotection Revenue & Forecasts
4.2.1 By Type - Global Neuroprotection Revenue, 2018-2023
4.2.2 By Type - Global Neuroprotection Revenue, 2024-2029
4.2.3 By Type - Global Neuroprotection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuroprotection Market Size, 2022 & 2029
5.1.2 Prevention
5.1.3 Treatment
5.2 By Application - Global Neuroprotection Revenue & Forecasts
5.2.1 By Application - Global Neuroprotection Revenue, 2018-2023
5.2.2 By Application - Global Neuroprotection Revenue, 2024-2029
5.2.3 By Application - Global Neuroprotection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Neuroprotection Market Size, 2022 & 2029
6.2 By Region - Global Neuroprotection Revenue & Forecasts
6.2.1 By Region - Global Neuroprotection Revenue, 2018-2023
6.2.2 By Region - Global Neuroprotection Revenue, 2024-2029
6.2.3 By Region - Global Neuroprotection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Neuroprotection Revenue, 2018-2029
6.3.2 US Neuroprotection Market Size, 2018-2029
6.3.3 Canada Neuroprotection Market Size, 2018-2029
6.3.4 Mexico Neuroprotection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Neuroprotection Revenue, 2018-2029
6.4.2 Germany Neuroprotection Market Size, 2018-2029
6.4.3 France Neuroprotection Market Size, 2018-2029
6.4.4 U.K. Neuroprotection Market Size, 2018-2029
6.4.5 Italy Neuroprotection Market Size, 2018-2029
6.4.6 Russia Neuroprotection Market Size, 2018-2029
6.4.7 Nordic Countries Neuroprotection Market Size, 2018-2029
6.4.8 Benelux Neuroprotection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Neuroprotection Revenue, 2018-2029
6.5.2 China Neuroprotection Market Size, 2018-2029
6.5.3 Japan Neuroprotection Market Size, 2018-2029
6.5.4 South Korea Neuroprotection Market Size, 2018-2029
6.5.5 Southeast Asia Neuroprotection Market Size, 2018-2029
6.5.6 India Neuroprotection Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Neuroprotection Revenue, 2018-2029
6.6.2 Brazil Neuroprotection Market Size, 2018-2029
6.6.3 Argentina Neuroprotection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuroprotection Revenue, 2018-2029
6.7.2 Turkey Neuroprotection Market Size, 2018-2029
6.7.3 Israel Neuroprotection Market Size, 2018-2029
6.7.4 Saudi Arabia Neuroprotection Market Size, 2018-2029
6.7.5 UAE Neuroprotection Market Size, 2018-2029
7 Neuroprotection Companies Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Neuroprotection Major Product Offerings
7.1.4 F. Hoffmann-La Roche Neuroprotection Revenue in Global Market (2018-2023)
7.1.5 F. Hoffmann-La Roche Key News & Latest Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Neuroprotection Major Product Offerings
7.2.4 Eli Lilly and Company Neuroprotection Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly and Company Key News & Latest Developments
7.3 Daiichi Sankyo Company
7.3.1 Daiichi Sankyo Company Company Summary
7.3.2 Daiichi Sankyo Company Business Overview
7.3.3 Daiichi Sankyo Company Neuroprotection Major Product Offerings
7.3.4 Daiichi Sankyo Company Neuroprotection Revenue in Global Market (2018-2023)
7.3.5 Daiichi Sankyo Company Key News & Latest Developments
7.4 Allergan
7.4.1 Allergan Company Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Neuroprotection Major Product Offerings
7.4.4 Allergan Neuroprotection Revenue in Global Market (2018-2023)
7.4.5 Allergan Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Neuroprotection Major Product Offerings
7.5.4 Novartis Neuroprotection Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Neuroprotection Major Product Offerings
7.6.4 AstraZeneca Neuroprotection Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Dr. Reddy's Laboratories
7.7.1 Dr. Reddy's Laboratories Company Summary
7.7.2 Dr. Reddy's Laboratories Business Overview
7.7.3 Dr. Reddy's Laboratories Neuroprotection Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Neuroprotection Revenue in Global Market (2018-2023)
7.7.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.8 Astrocyte Pharmaceuticals
7.8.1 Astrocyte Pharmaceuticals Company Summary
7.8.2 Astrocyte Pharmaceuticals Business Overview
7.8.3 Astrocyte Pharmaceuticals Neuroprotection Major Product Offerings
7.8.4 Astrocyte Pharmaceuticals Neuroprotection Revenue in Global Market (2018-2023)
7.8.5 Astrocyte Pharmaceuticals Key News & Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Neuroprotection Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Neuroprotection Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.10 Biogen
7.10.1 Biogen Company Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Neuroprotection Major Product Offerings
7.10.4 Biogen Neuroprotection Revenue in Global Market (2018-2023)
7.10.5 Biogen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
